Colorectal Cancer Market Demand Growing with Rising Diagnostic Requirements CAGR of 2.60% during the Forecast period

The global colorectal cancer market size at $9.5 billion as of 2018, and projects the overall revenue avenues to increment at a compound annual growth rate (CAGR) of 2.60% during the forecast period of 2019 to 2025.

Hyderabad, India - July 9, 2019 /MarketersMedia/ —

Colorectal cancer is deliberated as the third most common cancer in the world. The increasing geriatric population is the most colorectal cancer affected a segment of the society. Although cancer is a life-threatening disease, advancement in the therapeutic and drug sector has significantly cured numerous colorectal cancer cases. This resonates with the findings of an IndustryARC business report, which estimates the global colorectal cancer market size at $9.5 billion as of 2018, and projects the overall revenue avenues to increment at a compound annual growth rate (CAGR) of 2.60% during the forecast period of 2019 to 2025. This report covers Colorectal Cancer Market Size by type and applications, Colorectal Cancer Market share by top 5 companies and also the market share by start-ups during the forecast period.

The report is titled “Colorectal Cancer Market: By Testing & Diagnosis (Macroscopy, Microscopy, Immunochemistry, Staging, & Tumor Budding); By Therapies & Drugs & By Geography – Forecast (2019 - 2025).” This report is inclusive of company overview, trends, growth drivers, financial overview, business strategies, and recent developments.

View Full Table of Contents of Colorectal Cancer Market:
https://www.industryarc.com/Report/15559/colorectal-cancer-market.html

Colorectal Cancer Market: Leading Segments
By region, North America dominated the global colorectal cancer market with 28% of the total colorectal cancer market share in 2018. The North America colorectal market is fuelled by increased awareness of early detection, screening, and diagnosis. In the US, as of 2016, colorectal cancer was the fourth most common segment behind lunch, breast, and prostate. Furthermore, high investment in research and development, the presence of leading therapeutic and drug companies incorporated with sophisticated healthcare infrastructure and favorable reimbursement policies by the government are driving the North American colorectal cancer market.

Diagnostic imaging centers among other end-user applications are considered as the most lucrative sectors of the global colorectal cancer market. As per the analysis, this application is growing at a considerable CAGR of 4.10% during the forecast period of 2019 to 2025. The increased awareness about early detection and treatment about colorectal cancer is driving the demand influx in the colorectal cancer market.

Colorectal Cancer Market Industry Analysis
Abnormal body growth in the colon or rectum is considered as colorectal cancer. The American Cancer Society assessed that 39,910 new cases of rectal cancer and 95,520 instances of colon cancer were diagnosed in the United States in 2017. The increasing geriatrics populations and rising instances of colorectal cancer across the world is driving profits in the global colorectal cancer market. Additionally, the introduction and uptake of premium-priced treatments to cure the colon and rectum cancer are responsible for bolstering the growth in the global colorectal cancer market.

Colorectal Cancer Market Trends
• The overall death rate among men and women is dropping owing to the improved drug supply and chemotherapeutic processes. Pipeline drug suppliers are earning significant profits because of successful treatment that marked survival of more than 1 million colorectal cancer cases in the United States through the last decade.
• Despite new drugs, there remains hollow space for the treatment of resectable high-risk colorectal cancer. This calibration has considerate untapped needs and it possesses a productive opportunity for the producers of effective treatments that can optimize cure rates for resected patients.

Colorectal Cancer Market: Competitive Landscape
Some of the key companies identified in the report that are currently holding majority shares in the colorectal cancer market are F. Hoffmann-La Roche Ltd., Merck KGaA, Bayer HealthCare Pharmaceuticals, Boehringer Ingelheim, Taiho Pharmaceutical, Eli Lilly and Company, Pfizer, Inc., Abbott Diagnostics, Quest Diagnostics, Taiwan Liposome Company Ltd.

Talk to one of our sales representative about the full report by providing your details in the link below:
https://www.industryarc.com/support.php?id=15559

Related Reports:
A. In-Viro Colorectal Cancer Screening Tests Market
https://www.industryarc.com/Research/In-Vitro-Colorectal-Cancer-Screening-Tests-Market-Research-503801

B. Oncology Market
https://www.industryarc.com/Report/18335/oncology-market.html

About IndustryARC :
IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.

Contact Info:
Name: Venkat Reddy
Email: Send Email
Organization: IndustryARC
Phone: +1 614-588-8538
Website: https://www.industryarc.com/Domain/8/lifesciences-healthcare-market-research.html

Source URL: https://marketersmedia.com/colorectal-cancer-market-demand-growing-with-rising-diagnostic-requirements-cagr-of-260-during-the-forecast-period/88893647

Source: MarketersMedia

Release ID: 88893647